tretazicar has been researched along with bromodeoxyuridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Cheng, KY; Fennell, M; Ghavami, A; Howland, DS; Kwak, SP; Malberg, JE; She, Y; Su, J | 1 |
3 other study(ies) available for tretazicar and bromodeoxyuridine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Ablation of central nervous system progenitor cells in transgenic rats using bacterial nitroreductase system.
Topics: Animals; Animals, Genetically Modified; Animals, Newborn; Antineoplastic Agents; Aziridines; Behavior, Animal; Bromodeoxyuridine; Cell Line, Tumor; Central Nervous System; Dose-Response Relationship, Drug; Electroshock; Escherichia coli Proteins; Green Fluorescent Proteins; Humans; Injections, Intraventricular; Intermediate Filament Proteins; Nerve Tissue Proteins; Nestin; Nitroreductases; Rats; Rats, Sprague-Dawley; Stem Cells; Time Factors | 2007 |